Smell

Patients with advanced chronic kidney disease, particularly those on maintenance hemodialysis, may have reduced perception of smell, according to published data.

Approximately one-quarter of adults who lost taste or smell following SARS-CoV-2 infection reported partial or no recovery of their senses, a study published in The Laryngoscope found.

LOUISVILLE, Ky. — Dupilumab improved symptoms among patients with chronic rhinosinusitis with nasal polyps regardless of baseline severity of smell loss, according to study results.

Doctors should consider intranasal corticosteroids for patients with chronic rhinosinusitis who also have COVID-19 to minimize loss of olfactory function, according to a study published in Allergy and Asthma Proceedings.

Dupilumab and benralizumab both improved sense of smell in patients with chronic rhinosinusitis with nasal polyps, and benralizumab also decreased nasal blockage, according to results of two studies.

In patients with positive and negative SARS-CoV-2 test results, congestion and runny nose were associated with a new loss of taste or smell, suggesting these symptoms “may not be a valid marker of test positivity,” researchers wrote.

Women with postpartum depression experience smell differently than other women do, according to a study published by Scientific Reports.

Loss of smell, or olfactory dysfunction, may indicate an elevated risk for 5-year mortality, according to research published in JAMA Otolaryngology-Head & Neck Surgery.

While gastrointestinal symptoms like anorexia and diarrhea are common in both patients with COVID-19 and those without, these symptoms plus a loss of smell, taste and fever were 99% specific for COVID-19, according to a study published in Gastroenterology.